Yeung, MD, MPH Darren Lau, MD, PhD, FRCPC Volume 46, Issue 7 p691-698October 2022 This article reviews the impact of new diabetes treatment guidelines on the eligibility for sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists in Canada, assessing how the revised criteria affect patient access to these medications
Bring documentation
Learn More Join 1,500,000 other scientists on BioRender Sign up for your free account and start creating scientific figures faster today Sign Up Free FAQs BioRender is a webbased software that helps you create scientific figures in minutes
Using 16s rRNA sequencing from faeces is a reliable, established and inexpensive way of microbiome assessment, however taxonomic resolution and coverage are limited
Using bacteriostatic water rather than sterile saline extends the stability of the reconstituted solution to approximately 30 days under refrigeration
Traveling with syringes and tirzepatide When traveling, keep your tirzepatide in an insulated cooling case with gel packs
